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The Aspergillus NIMA serine/threonine kinase plays a pivotal role in controlling entrance into mitosis. A major function attributed to NIMA is
the induction of chromatin condensation. We show here that the founder murine NIMA-related kinase, Nek1, is larger than previously reported,
and that the full-length protein conserves the structural hallmarks of NIMA. Even though Nek1 bears two classical nuclear localization signals
(NLS), the endogenous protein localizes to the cytoplasm. Ectopic overexpression of various Nek1 constructs suggests that the C-terminus of
Nek1 bears cytoplasmic localization signal(s). Overexpression of nuclear constructs of Nek1 resulted in abnormal chromatin condensation, with
the DNA mainly confined to the periphery of the nucleus. Advanced condensation phenotype was associated with nuclear pore complex dispersal.
The condensation was not accompanied by up-regulation of mitotic or apoptotic markers. A similar phenotype has been described following
NIMA overexpression, strengthening the notion that the mammalian Nek1 kinase has functional similarity to NIMA.
© 2006 Elsevier B.V. All rights reserved.Keywords: NIMA; Nek kinase; Chromatin condensation; Cell cycle; Sub-cellular localization1. Introduction
The Aspergillus NIMA kinase, is required by this fungus for
entry into mitosis [1,2]. As implied by its name (never in mitosis
A), in the conditional absence of NIMA activity, fungal cells
cannot enter mitosis and they are arrested in G2, exhibiting
interphase microtubules and uncondensed chromosomes [3,4].
The mitotic activation of NIMA is probably achieved through
autophosphorylation, followed by hyperphosphorylation by
Cdc2 [5]. Overexpression of NIMA results in premature
chromatin condensation from any phase of the cell cycle; this
effect is independent of Cdc2 activation. Consistent with this
phenotype, it has been demonstrated that overexpression of
NIMA in Aspergillus triggers histone H3 phosphorylation on
Ser-10, a phosphorylation event connected with mitotic
chromatin condensation [6]. An additional documented task
of NIMA is the nuclear localization of cyclin B [7], possibly by
phosphorylation of nuclear pore complex (NPC) proteins [8].⁎ Corresponding author. Tel.: +972 3531 8149; fax: +972 3535 8124.
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doi:10.1016/j.bbamcr.2006.01.009NIMA is localized to the NPC during early mitosis, and is
essential for NPC proteins dispersal [9].
Several observations suggest that the NIMA pathway is also
evolutionarily conserved. Thus, overexpression of the fungal
NIMA kinase in Xenopus oocytes induces germinal vesicle
breakdown, and overexpression in human HeLa cells results in
premature chromatin condensation without mitotic spindle
formation [2,10]. In addition, similar to the phenotype in
Aspergillus, overexpression of dominant-negative variants of
NIMA in human cells results in characteristic G2 arrest [2].
Finally, mammalian genomes encode for a family of NIMA-
related kinases (designated Nek1 to Nek11), which are natural
candidates for performing NIMA-like mitotic activities, and
recent data suggests several common characteristics [11].
Among the mammalian Nek proteins, Nek2 has the greatest
sequence similarity, within the kinase domain, to NIMA. Its
major activities are associated with centrosomal, spindle and
kinetochore-related functions [12,13]. Nek2 has also been
shown to be localized to condensing meiotic chromosomes
[14], and to be involved in meiotic chromatin condensation,
probably by interacting with, and phosphorylation of, the
architectural chromatin protein, HMGA2 [15,16]. Recently,
mitotic roles have been demonstrated for another Nek member,
Nek9/Nercc1, and for its interacting proteins, Nek6 and Nek7
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phase progression was suggested by virtue of Nek9 binding to
FACT, a nuclear complex active in regulation of the chromatin in
relation to DNA replication and transcription [21]. Taken
together, the mammalian Nek kinases have been shown to be
involved in various aspects of cell cycle control, but there is no
evidence for their direct involvement in chromatin condensation.
Inherited mutations in the nek1 gene in mice result in several
developmental defects. The mutants suffer from dwarfism and
early mortality. Animals that survive to adulthood are either
sterile (males) or subfertile (females), and develop polycystic
kidneys [22]. Even though Nek1 was the first mammalian
NIMA-related gene to be cloned [23], its cellular or molecular
functions are unknown. We report here that Nek1 has greater
structural similarity to NIMA than previously reported. Over-
expression of truncated Nek1 variants induces chromatin
condensation resembling the phenotype induced by NIMA
overexpression in vertebrate cells.2. Materials and methods
2.1. Plasmid construction
For construction of Nek1 expression vectors, we used the Nek1–not12
fragment [23]. A unique SalI site was added by adaptor ligation just upstream
to the initiator Met, and the SalI–NotI fragment was cloned into corresponding
sites of pCMV-Myc (Clontech). This fragment encodes a slightly shorter
polypeptide than the full-length protein, encompassing amino acids 1–1146.
For construction of the full-length protein, extension of the original Nek1–
not12 fragment was performed using a 3′ fragment from the not18 clone [23].
Site-directed mutagenesis at the ATP-binding site (G13R) was carried out
using the QuikChange kit (Stratagene, La Jolla, CA), with primers: 5′ CAGA-
AGATTGGAGAACGTTCATTTGGAAAAG 3′ and 5′ CTTTTCCAAAT-
GAACGTTCTCCAATCTTCTG 3′. Wild type and G13R full-length vectors
were then truncated by cutting with BglII and NotI, followed by mung bean
nuclease digestion and self-ligation (resulting in constructs N-1001, and N-
1001G13R). An additional truncation, using XcmI and NotI resulted in construct
N-753. Removal of an internal XhoI fragment resulted in the FLΔ151–438
construct. The first NLS mutations (K365 R366/AA) were generated using the
QuikChange kit and the primers: CTGAGGAAGCAGCAAAAGCAG-
AAGGTTGGAATTTATTGAGAAAG and CTTTCTCAATAAATTCCAA-
CCTTGCTGCTTTTGCTGCTTCCTCAG, and the second NLS mutation
K581R582/AL) using the primers: GAAGACCTGGACCGAGCTCTGAAG-
CAGAGCTCGCTCCAGCTGTTC. NES mutations (L1131G, L1134A) were
generated using the primers: 5′ CAGTGTCTTTAACCATGGAGAGGAAG-
AAGACTTCACTTGGAGCAAG 3′ and 5′ CTTGCTCCAAGTGAAGTC-
TTGCTTCCTCTCCATGGTTAAAGACACTG 3′ using the QuikChange kit.
The 764 NES sequence was mutated (L644G, L767S) using the primer
ATGGCTCTCCAAGAAAAGTCTGGGGGAAAAACCCTACAGATTCTG-
TGGGGAAGATATCTGGAGAAGCTGAATTACAGC in a PCR reaction.
2.2. Sequence analyses
PEST predictions were run online at http://www.at.embnet.org/embnet/
tools/bio/PESTfind/, at a window of 10.
Nuclear localization signal (NLS) predictions were performed at http://
cubic.bioc.columbia.edu/predictNLS/.
2.3. Transfections
HeLa, NIH3T3 and HEK293 cells were transiently transfected using
CellPhect Transfection kit (Amersham, Pharmacia Biotech) according to the
manufacturer's instructions.2.4. Immunocytochemistry
Polyclonal antibodies against Nek1 were raised against two different
domains: I. A SphI–HindIII fragment encoding the N-terminal 187 amino acids
(and 2 amino acids upstream of the initiating methionine), inserted into the
pQE30 vector (Qiagen,Valencia, CA) downstream and in-frame with a 6XHis
tag. II. A BglII–NotI fragment encoding the C-terminal 204 amino acids inserted
into the pGEX-4T-2 vector downstream and in-frame with the GST tag. Purified
proteins were injected into rabbits, and the resulting antibodies were affinity-
purified using the corresponding Nek1 fragment coupled to an activated
cyanogen bromide Sepharose column (Sigma). Antiserum was passed over the
column and eluted with 100 mM glycine, pH 2.5, into 1 M Tris, pH 9.5.
For immunofluorescence microscopy, cultures grown on coverslips were
fixed in 4% paraformaldehyde for 20 min., blocked with 3% BSA/0.5% Triton
X-100 in PBS, and incubated overnight with primary antibodies at 4 °C. Primary
antibodies were used as follows: Nek1 purified polyclonal antibodies diluted
1:50, Myc-monoclonal antibodies (Zymed Laboratories, CA) 1:250, HA-
monoclonal antibodies (BAbCO, Richmond, CA) 1:1000, mouse α/β Tubulin
(Biomeda, Foster City, CA) 1:1000, rabbit anti P-S10-Histone-H3 (Upstate
Biotechnology, NY) 1:100, and rabbit anti activated Caspase-3 (Cell Signaling)
diluted 1:75. Following washes, the coverslip was incubated with fluorescein
isothiocyanate (FITC)-conjugated anti-mouse and/or Rhodamin-conjugated
anti-rabbit secondary antibodies (Jackson ImmunoResearch) (1:150). DNA
staining was done with propidium-iodide solution, and the coverslips were
mounted on slides with Vectashield mounting solution (Vector, Burlingame,
CA) and sealed. Staining was analyzed using an MRC 1024 confocal laser
microscope (Bio-Rad).
2.5. Cell fractionation
Cells were washed twice by PBS and harvested by lysis buffer (10 mM
NaCl, 3 mM MgCl2, 10 mM Tris–HCl pH=7.5, 0.5% NP-40). The extracts
were homogenized by a syringe needle (21G, 25 times), and centrifuged for 3 s
at 20,000×g at room temperature. SDS sample buffer was added to the
supernatant that were marked as cytoplasm. The pellet was washed twice by
lysis buffer, followed by spin down for 5 s. The pellet was dissolved by SDS
sample buffer and marked as nucleus.3. Results
3.1. Nek1 protein structure is highly similar to that of NIMA
The murine Nek1 kinase was reported to consist of 774
amino acids, with a calculated molecular weight of 88.4 kDa,
and limited structural homology to NIMA [23]. However,
antibodies raised against the N-terminus portion of Nek1
detected a prominent band at about 180 kDa in Western analysis
of various murine tissue extracts, indicating that the translated
product is larger than originally predicted (see below). We thus
compared the reported nek1 cDNA sequence to the deposited
murine sequences in the various data bases (genomic, cDNAs
and ESTs), and sequenced one of the original clones (clone 23,
described in [23]). The sequence analysis suggested that two
reading mistakes occurred in the original report (T instead of C
was reported at nucleotide 2898, and G following nucleotide
3869 was omitted; the corrected sequence has been deposited in
NCBI GenBank Accession No. AY850065). According to the
corrected open reading frame, the murine Nek1 encodes a 1203
amino acid protein, with a calculated molecular weight of 136.7
kDa (Fig. 1A). Nek1 is the longest documented NIMA-family
kinase, bearing a 945 C-terminal non-catalytic tail. As the C-
terminus is highly enriched in acidic residues, the overall
Fig. 1. Nek1 sequence and structure. (A) Complete sequence of the mouse Nek1 protein. The putative NLS motifs are highlighted by bold and underline. The carboxy
extension (starting at position 774, marked with an asterisk) described in the text harbors potential PEST-rich sequences (proline, glutamine, serine and threonine-rich) (dashed
underscore) and a putative NES (nuclear export sequence) (double underscore). The mutated NES leucines are in bold. (B) Schematic comparison of the structures of NIMA
and Nek1. Paircoil analysis of NIMA sequence predicts one coiled-coil region (at a window of 28 residues, cutoff of 0.5), two potential PEST sequences and an NLS. Nek1
contains five predicted coiled-coil regions, five PEST-rich regions, and two classical NLS motifs. C. Major Nek1 constructs used in this study. Nek1 constructs were tagged
with Myc at the N- or C-terminus. The subcellular distribution of the constructs 48 h after transfection, and the observed chromatin condensation phenotype are indicated.
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very basic (9.46), reported previously [23]. According to the
corrected sequence, Nek1 and NIMA proteins share several
important characteristics (Fig. 1B): (A) As is the case with
NIMA, and with several NIMA-related kinases, classical
nuclear localization signals follow the catalytic domain. (B) A
prominent portion of the Nek1 tail is composed of predicted
coiled coil domains (at amino acids 350–410; 475–510; 525–
600; 640–685 and 1035–1065). Coiled coil domains have been
reported for NIMA and for several Nek kinases including Nek2,
Nek8/Nercc1 and Nek11 [24,17]. For Nek2 and Nercc1, the
coiled coil domains have been demonstrated to be essential for
homodimerization and for autophosphorylation and activation
[24,17]. (C) Like NIMA, Nek1 harbors several potential PEST
sequences implicated in regulated protein degradation (at amino
acids 810–824, 827–858, 911–927, 1018–1079 and 1088–
1110). (D) Candidate mitotic phosphorylation sites in NIMA
(SP and TP) also prevail in Nek1. Interestingly, SP repeats 13
times (including 3 times in the sequence SPSPCSP, immediately
following the first putative NLS), while TP appears only once.
These structural similarities strengthen the notion that Nek1
may have NIMA-related activities.
Even though the calculated molecular weight of Nek1 is
about 137 kDa Western analyses of extracts from several cell
lines and from mouse tissue lysates, with antibodies raised
against the C-terminal 203 amino acids of Nek1 detected aFig. 2. Endogenous Nek1 expression. (A) Western blot analysis of Nek1 expression
purified antibodies directed against the C-terminus of Nek1. The membrane was re-b
Nek1 expression in extracts of the indicated tissues from wt and katmutants, using aff
was re-blotted with anti-αβ tubulin antibodies to assess loading. (C) Immunolocaliza
to FITC) in embryonic fibroblasts from wt mice (upper panel), and kat mutants (lowprominent band running as a 180-kDa protein, and much fainter
band at around 95 kDa (Fig. 2A, and see below). The same slow
mobility was observed following overexpression of tagged full
length Nek1 protein. The slower migration is probably not due to
phosphorylation, as omission of phosphatase inhibitors in the
extractions, and incubation with calf intestine phosphatase did
not significantly affect Nek1 migration (not shown). The reason
for the slow electrophoretic mobility is currently obscure, and it
worth noting in this regard that similar slow migration
phenomenon has been recently reported for the active Nek9/
Nercc1 protein [25].
In accordance with the reported RNA expression patterns
[23,26], highest levels of Nek1 protein were found in the testis,
while lower levels were detected in ovary, lung, brain, heart and
spleen (Fig. 2B, and not shown). Nek1 null Kat2J mice did not
exhibit any protein staining (Fig. 2A, B), confirming the
specificity of the antibodies, and that this mutant is truly null for
Nek1 [22].
3.2. The full-length Nek1 protein is mainly cytoplasmic
The Aspergillus NIMA protein bears nuclear localization
signals (NLS) and is temporarily localized to the nucleus during
fungal mitosis [6]. However, overexpression of NIMA in
mammalian cells results in cytoplasmic localization [27]. Nek1
protein contains two classical nuclear localization signalsin extracts of 12.5 days embryonic heads of wt and kat mutants, using affinity-
lotted with anti-actin antibodies to assess loading. (B) Western blot analysis of
inity-purified antibodies directed against the C-terminus of Nek1. The membrane
tion of endogenous Nek1 (stained with secondary anti-rabbit antibodies coupled
er panel). The nuclei were counterstained with propidium-iodide.
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chemistry with antibodies raised against the C-terminal portion
of Nek1 demonstrated cytoplasmic localization of Nek1 in
embryonic fibroblasts (Fig. 2C), and in various tissues (not
shown).
To probe the sequences responsible for the subcellular
localization of Nek1, a series of tagged Nek1 protein deletions
and truncations was constructed and their subcellular localiza-
tions were examined following transient transfections into the
HeLa, NIH3T3 and HEK293 cell lines (for schematic presen-
tation of the various deleted/truncated constructs, and their
localizations see Fig. 1C). Overexpression of full-length
proteins tagged in either the C- or N-terminus resulted in
almost exclusive cytoplasmic staining (Fig. 4A). Constructs
containing the N-terminal 753 or 1001 amino acids of Nek1 (N-
753 and N-1001, respectively), which include the putative
NLSs, were found to shift from being mostly distributed in both
the nucleus and the cytoplasm shortly following transfection, to
nuclear localization by 48 h after transfection (Fig. 5A).
However, the distribution of the full-length (FL) and almost full
length Nek1 proteins (to amino acids 753 or 1146, N-753 and
N-1146, respectively) were cytoplasmic, and did not change
with time. Cell fractionation confirmed the restriction of the FLFig. 3. Nek1 cleavage, cellular localization and co-precipitation. (A) Overexpression o
N-1001) results in a prominent band of about 40 kDa. No such band is observed follow
Cell fractionation of the full-length and the 40-kDa fragment. The 40-kDa is localiz
cytoplasmic and nuclear markers, respectively. (C) Cell fractionation of the truncated
1001 proteins. Left panel-myc-tagged FL and N-1001 proteins overexpressed in HEK
co-immunoprecipitation of HA-tagged FL protein by co-expressed FL myc-tagged pprotein to the cytoplasm, and that the truncated protein are
found in both the cytoplasm and the nucleus (Fig. 3C, and not
shown).
To test the involvement of the putative NLS signals in the
nuclear entrance, we mutated each of the putative NLS signals.
Quite surprisingly, the mutations mildly reduced, but did not
avoid, the entrance into the nucleus of the N-753 and N-1001
constructs (Fig. 1C). In addition, Nek1 fragment containing the
second putative NLS motif (containing a.a. 439–1001) was
entirely cytoplasmic, suggesting that this NLS motif
(RKRK583) is non functional. Taken together, these results
suggest that while Nek1 contains two classical NLSs, the full-
length protein is cytoplasmic, as amino acids 1001–1146
contain sequences that inhibit nuclear localization. Truncated
proteins, missing the C-terminus, localized to the nucleus
following a delay, and their entrance is not solely dependent
on their classical NLS motifs.
3.3. Nek1 cytoplasmic localization in not due to nuclear export
Two possible models can explain the contribution of the C-
terminus to the cytoplasmic localization. It is possible that the
C-terminal tail masks motifs essential for nuclear localizationf Nek1 constructs harboring myc tag in the N-terminus (myc-FL-Nek1 and myc-
ing overexpression of FL protein tagged in the C-terminus (FL-myc-Nek1). (B)
ed both to the cytoplasm and to the nucleus. Tubulin and Histone H3 serve as
and NES-mutated Nek1 constructs. (D) Co-immunoprecipitation of FL and N-
293 cells and detected byWestern blotting with anti-myc antibodies. Right panel-
rotein, but not by co-expressed myc-tagged N-1001 protein.
Fig. 4. FL Nek1 is localized to the cytoplasm and induces multinucleation in
HeLa cells. (A) Staining of HeLa cells transfected with FL Nek1 construct
showing distribution of transfected protein. (B and C) Overexpression of FL
Nek1 (B) or a deleted form (FLΔ151−438) (C), induces the formation of giant,
multinucleated cells.
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intramolecular folding. Alternatively, the C-terminal fragment
could contain sequences that retain Nek1 in the cytoplasm,
either by docking it to cytoplasmic elements or by inducing
nuclear export. Assuming the first explanation, addition of an
ectopic NLS signal to Nek1 protein should lead to Nek1
entrance into the nucleus. However, hooking three repeats of the
SV40 NLS to the C-terminus of Nek1 (yielding Nek1-myc-
NLS) resulted in only low percentage of cells in which Nek1
was localized to the nucleus (Fig. 1C).
Examination of the C-terminal fragment revealed a potential
nuclear export sequence (NES): 1127VFNHLEELRLHL1138,
which conforms to the NES consensus (and an additional
putative NES signal starting at a.a. 764, LKILGEAELQL). To
examine the functionality of these plausible NES, the two of the
leucine residues were mutated (creating the sequences
VFNHGEEARLHL and GKISGEAELQL). Analogous muta-
tions in different NES sequences cripple nuclear export
induction by corresponding elements [28]. However, the double
NES-mutated FL protein remained in the cytoplasm, suggesting
that these sequences are not essential for the cytoplasmic
retention of Nek1 (Fig. 3C, and not shown).
We next examined the possible contribution of Nek1 kinase
activity to Nek1 localization. Autophosphorylation kinase
assays for immunoprecipitated myc-Nek1 constructs over-
expressed in HEK293 cells confirmed the activity of the
kinase-containing constructs (not shown). To generate a kinase
negative version of Nek1, the invariant Gly at a.a.13 was
mutated to Arg (designated G13R) (at the ATP-binding site;
kinase subdomain I). The cytoplasmic distribution of the full-
length construct, as well as the nuclear localization of the N-
1001 construct, were not affected by the G13R mutation (Fig.
1C), suggesting that Nek1 localization is not dependent on its
enzymatic activity.
Interestingly, in Western analyses of overexpressed Myc-
Nek1, we consistently observed a prominent Nek1 band of
about 40 kDa (and slighter additional band of about 85 kDa),
corresponding to the N-terminal portion of Nek1 (containing the
kinase domain and the first NLS) (Fig. 3A). It is thus possible
that a specific proteolytic processing step yields a putative
nuclear kinase, which could explain the weak nuclear signal
observed following overexpression of the full-length Nek1
sequence. Indeed, cell fractionation revealed that while the FL
180 kDa protein is almost exclusively restricted to the
cytoplasm, the 40 kDa fragment is equally distributed in the
nucleus and the cytoplasm (Fig. 3B).
3.4. Overexpression of truncated Nek1 protein results in
chromatin condensation
Forced expression of NIMA in mammalian cells disrupts the
cell cycle [2]. Examination of HeLa cells overexpressing the
myc-Nek1 constructs revealed an elevated frequency of
multinucleated cells. At 72 h following transfection, a
significant portion of the transfected cells (∼5%) had three or
more nuclei, with bulky cytoplasm (Fig. 4B). Many of these
giant cells displayed unevenly-sized or lobed nuclei. Interest-ingly, this phenotype was also observed following transfec-
tion with a construct missing most of the catalytic domain
(FLΔ-151–438, Fig. 4C). Thus, the phenotype is not dependent on
Nek1 kinase activity. Such multinucleated huge cells were rarely
observed in HeLa cells transfected with a construct containing
GFP alone, or in cells transfected with a construct containing an
internal Nek1 fragment (a.a. 151–438) (<1%, not shown).
Intriguingly, following transfection of HeLa cells with the
construct harboring the first 753 or 1001 amino acids of Nek1, a
dramatic change in chromatin staining was noticed. By 24
h after transfection, some of the cells had uneven chromatin
distribution, with higher condensation at the periphery of the
nucleus (not shown). As noted before, by 24 h the truncated
Nek1 constructs were localized to the nucleus in only about
18% of the cells, and the phenotype almost exclusively
appeared in the cells exhibiting nuclear Nek1 localization. By
48 h, there was clear correlation between N-1001 localization
and the cellular phenotype. In almost all of the cells, N-1001
was found in either the nucleus or in both the nucleus and the
cytoplasm. Within this population, in about 60–70% of the
cells, DNA staining revealed dense peripheral chromatin ring,
concomitant with appearance of large unstained spaces within
the nuclei of the transfected cells (Fig. 5A). DNA condensation
was also apparent around nucleoli (white arrows in Fig. 5A, and
not shown). Nuclear N-1001 localization was restricted to the
nucleoplasm, and was absent from nucleoli spaces (Fig. 5A).
However, in cases that N-1001 was localized to the cytoplasm,
no chromatin condensation was observed.
Fig. 5. Nek1 overexpression induces chromatin condensation. (A1–3) Transfection with a construct harboring amino acids 1–1001, followed by staining for
propidium-iodide (PI) and Myc-tag (left panel). A merged view is seen in the right panel. Nek1 localization to the nucleus (marked by an arrow) was correlated with
induction of chromatin condensation. Note that the chromatin distribution is mostly peripheral and around the nucleoli. Cell displaying N-1001 cytoplasmic
localization (marked by arrowhead) does not exhibit the chromatin condensation phenotype. (A4–7). Actin fiber and (A8–11) microtubule staining in N-1001
transfected cells. (B) Co-overexpression of HA-FL Nek1 (green) and myc-N-1001 (blue). Chromatin condensation phenotype did not affect the FL protein
localization. (C) Nup53-GFP localization in N-1001 overexpressing cells. (C1–2) Nup53-GFP localization in control cells. (C3–4) Early condensation phenotype of
N-1001 transfected cells did not affect Nup53 distribution. (C5–8) Cells exhibiting strong chromatin condensation. Note Nup53 diffused staining.
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cells which demonstrated chromatin condensation revealed
decrease in cell extensions and some reduction in actin stress
fibers density, and microtubule staining (Fig. 5A4–11). Moreadvanced and stronger condensation was accompanied by cell
rounding and sharp reduction in microtubule staining (not
shown). In the cases in which N-1001 protein was cytoplas-
mic, the transfected cells did not exhibit chromatin
Fig. 6. Chromatin condensation induced by N-1001 overexpression is not
coupled to Histone-H3 phosphorylation or Caspase 3 activation. (A) Cells were
transfected with N-1001 construct and stained for N-1001 (green) and anti p-
Ser10 (red). (B) Cells were transfected with N-1001 construct and stained for
DNA (PI-red), for N-1001 construct (blue), and for apoptotic cells with
antibodies against activated Caspase 3 (green).
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alteration.
Similar chromatin condensation was also observed in all of
the Nek1 constructs exhibiting nuclear localization, including
FL-myc-NLS in which the full-length protein was forced into
the nucleus. Transfection with a kinase-mutated version of the
N-1001 protein (N-1001G13R) yielded much weaker chromatin
condensation phenotype, and appeared in smaller fraction of the
transfected cells (approx. 40% of the cells expressing the
protein in the nucleus).
NIMA has been shown to interact genetically with
nucleoporin proteins, and it has been suggested that NIMA-
nucleoporin interaction is critical for dispersal of some NPC
proteins, and aids in the transport of mitotic regulators into
the nucleus during the fungal closed mitosis [6,7,9]. Over-
expression of NIMA in mammalian cells induces nuclear
membrane and nucleoporin dispersal [2]. We therefore
examined whether N-1001 influences nucleoporin localiza-
tion. Co-transfection of N-1001 and the nucleoporin Nup53-
GFP revealed N-1001 nuclear staining in cells with intact
nucleoporin localization (Fig. 5C1–4), suggesting that Nek1
nuclear entrance and (initial) chromatin condensation are
independent of nuclear membrane breakdown and nuclear
pore disassembly. However, advanced chromatin condensation
was accompanied with diffuse Nup-53-GFP staining, or its
disappearance (Fig. 5C5–8).
The observed correlation between N-1001 nuclear localiza-
tion and chromatin condensation could reflect the initial effect
of the truncated Nek1 on protein traffic through the nuclear
pores, which would consequently allow N-1001 entrance into
the nucleus. Next, we wondered whether the overexpression of
the N-1001 protein could affect the nuclear pore properties thus
allowing FL-protein entrance into the nucleus. To this end, we
co-transfected the FL-Nek1 (HA-tagged) construct with the N-
1001 (myc-tagged) species. Co-transfected cells exhibited the
chromatin condensation phenotype, however, the FL-protein
localization was not influenced and it remained almost
exclusively cytoplasmic (Fig. 5B), suggesting that the different
distribution of the FL versus the C-terminally truncated proteins
is not solely due to disruption of the nuclear membrane by the
truncated proteins.
Overexpression of two different FL-Nek1 constructs tagged
with either HA or Myc in HEK293 cells followed by reciprocal
co-precipitation suggested that the Nek1 protein is expressed as
a dimer (or oligomer) (Fig. 3D). In agreement with the distinct
localization of the co-expressed constructs, the FL-Nek1
construct did not precipitate the N-1001 protein. The
dimerization motif is thus localized in the C-terminal 203
amino acids, the same region which governs the cytoplasmic
retention.
3.5. Chromatin condensation induced by Nek1 does not induce
phosphorylation of Histone- H3 Ser10 and is not due to
apoptotic events
Chromatin condensation during mitosis is coupled to
phosphorylation of histone H3 on serine-10, and this phos-phorylation serves as a common marker for mitotic chromatin
condensation. To examine whether the change in chromatin
structure resulting from Nek1 overexpression is associated with
phosphorylation of serine-10, cells were stained with antibodies
that specifically recognize P-S10. Whereas mitotic cells stained
positively for P-S10, N-1001 transfected cells did not exhibit
histone phosphorylation (Fig. 6A).
Condensation of the chromatin into a peripheral nuclear ring
characterizes some early and transient forms of apoptosis.
However, the DNA of spontaneously apoptotic HeLa cells or
etoposide-induced apoptotic cells appeared discontinuous and
punctuated, while the DNA of N-1001 transfected cells formed
an uninterrupted ring. In addition, by 48 h post-transfection,
classical apoptotic nuclear morphology of condensed oligonu-
cleosomal chromatin fragments [29] was rarely observed in the
N-1001 transfected cells. To rule out the possibility that the
abnormal chromatin staining observed following N-1001
overexpression represented early stages of an apoptotic event
that was then been stabilized, HeLa cells were harvested 24 or
48 h following N-1001 transfection. Comparison of N-1001 to
control-DNA transfected cells, did not show a significant
difference in the percentage of sub-G1 phase cells in FACS
analysis, or of Annexin-V stained cells (data not shown).
Apoptosis is usually correlated with the activation of the
caspase cascades, ultimately leading to activation of the effector
caspases 3, 6 and 7 [30]. Gene targeting of caspase 3
demonstrated that it is essential for apoptotic chromatin
condensation and DNA degradation [31]. To examine possible
involvement of caspase 3 in Nek1-induced chromatin conden-
sation, HeLa cells were transfected with N-1001, fixed after 48
h, and stained for DNA (propidium iodide), the Nek1 myc tag,
and activated caspase 3. No correlation was found between
Nek1 induced chromatin condensation and caspase 3 activity
(Fig. 6B). These results suggest that the changes in chromatin
structure following N-1001 transfection are not mediated by
280 E. Feige et al. / Biochimica et Biophysica Acta 1763 (2006) 272–281caspase 3, and that the chromatin condensation is not due to an
apoptotic event.
4. Discussion
While the founding member of the mammalian NIMA-like
family, Nek1, was characterized about a dozen years ago, the
cellular and molecular roles of Nek1, and their possible
relationship to the documented mitotic roles of NIMA are still
enigmatic. Absence of Nek1 activity (as in the kat mutant
mouse) leads to dwarfism, male-specific sterility and polycystic
kidneys [22]. No overt mitotic phenotype is observed in the
mutants, though the polycystic kidney disease and the dwarfism
could result from a cell cycle defect. The corrected full-length
Nek1 sequence presented here extends its structural similarity to
NIMA, strengthening the likelihood that Nek1 performs NIMA-
like activities.
Our results indicate that Nek1 protein bears two classical
NLS, yet the full-length protein is cytoplasmic. Deletion
analyses identified a segment spanning amino acids 1002–
1145 as responsible for the cytoplasmic localization of the full-
length protein. Although this segment contains a classical
nuclear export signal our experiments suggest that this putative
NES sequence is not functional in the native protein. Thus, the
1002–1145 fragment of Nek1may retain Nek1 in the cytoplasm,
as a result of intramolecular folding that masks the NLS, or by
binding to a cytoplasmic protein. Alternatively, it is possible that
additional, unidentified, nuclear export signals reside in this
fragment, which interacts directly with an export protein, or
indirectly with a protein bearing NES. According to this pos-
sibility, Nek1 may shuttle between the cytoplasm and the nu-
cleus. Interestingly, in Aspergillus cells, NIMA enters the
nucleus towards mitosis [6], and it has been shown to influence
cyclin B localization to the nucleus [8]. This activity could be
compensated by a mutation in the nucleocytoplasmic transporter
SONA/RAE1 [8]. It has been recently shown that the nucleo-
porins SONA and SONB control the entrance of NIMA into the
nucleus, and it has been proposed that NIMA phosphorylates
these nucleoporins and thereby regulates themitotic nuclear pore
complex [7,9]. However, it is not clear whether NIMA itself
shuttles between the two compartments, and which determinants
control the temporal NIMA localization.
Overexpression of several cytoplasmic Nek1 constructs
resulted in an increased frequency of multinucleated cells. The
nuclei were usually of uneven size and micronuclei were
frequently observed. Highly similar phenotypes have been as-
sociated with overexpression of Nek9/Nercc1 [17], and
mutated or kinase-defective Nek8 [32]. Inactivation of Nek8
in jck mutant mice and of Nek1 in kat mutants both result in
severe polycystic kidney. Thus, Nek1 and Nek8 could operate
in the same signal transduction cascade, or might be
components of the same complex. However, coimmunopreci-
pitation assays of Nek1 and Nek8 failed to detect association
between the two proteins, and co-overexpression of Nek1 and
mutant Nek8 constructs did not result in a synergistic effect in
the frequency of the multinucleation phenotype (unpublished
results).Overexpression of the nuclear N-1001 or N-753 constructs
results in a striking phenotype. The chromatin appears
condensed and is localized mainly to the periphery of the
nucleus. Examination of N-1001 localization suggests that the
protein is initially mainly cytoplasmic (or perinuclear), and
nuclear entrance is correlated with chromatin condensation. We
therefore suggest that cytoplasmic Nek1 expression affects
(directly or indirectly) the nuclear membrane or the nuclear pore
complex, allowing Nek1 entry into the nucleus. The catalytic
activity of Nek1 contributes, but is not critical for this process,
as the kinase-dead N-1001 version exhibits a similar, albeit
much weakened and less frequent, chromatin condensation
phenotype. The lack of chromatin condensation activity of the
FL Nek1 protein could be due to its quite strict cytoplasmic
localization, or to a difference in the spectrum of cellular
proteins with which it interacts. Even though the FL protein did
not demonstrate chromatin condensation activity in our
experiments, it is possible that under some conditions, either
as a result of Nek1 modification, or truncation of the C-
terminus, Nek1 may enter the nucleus and become involved in
chromatin modifications. Interestingly, it has been recently
demonstrated that following ionizing radiation, Nek1 protein
could be found in discrete nuclear foci, in colocalization with
other DNA damage response proteins [33]. It is notable in this
regard, that in addition to the expected full-length Nek1 protein,
we identified a major band of about 40 kDa, probably
representing truncation at around amino acid 350, C-terminal
to the first NLS, and cell fractionation suggests that it could
enter the nucleus.
Overexpression of NIMA in mammalian cells has been
reported to induce peripheral ‘worm-like’ chromatin condensa-
tion [2]. This effect is distinct from the mitotic chromatin
condensation in Aspergillus. In fungal cells, NIMA activity
induces mitotic-like histone-H3 phosphorylation on ser-10,
while no such phosphorylation has been documented in
mammalian cells following either NIMA [27], or N-1001
overexpression. A similar condensation phenotype was recently
reported following MLK3 overexpression, a kinase which
shares sequence similarity with NIMA in the non-catalytic
domain [27]. It should be noted, however, that the NIMA and
MLK3 effect was observed even though the proteins were
mainly cytoplasmic [27]. Nevertheless, the nuclear phenotype
of NIMA and MLK3 could be due to leakiness, or to shuttling
through the nucleus. Alternatively, as NIMA was reported to
induce nuclear membrane breakdown and P62 nucleoporin
dispersal in HeLa cells [2], it is possible that the chromatin
effect is induced following NIMA's entrance into the nucleus.
Our results indicate that Nek1 could be involved in chro-
matin condensation. Nevertheless, null mutants for the nek1
gene, kat mice, suffer from developmental abnormalities, but
they do not exhibit an obvious cell cycle defect. It is possible
that the absence of Nek1 is compensated by the activity of
another (Nek) kinase. Alternatively, as the highest expression
levels of nek1 were observed in the developing germ cells, and
mutants of Nek1 suffer from sterility, it is possible that Nek1 is
involved in meiotic chromatin condensation. Nek1 molecular
pathways and cellular targets are yet to be explored.
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